X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2000) 2000
pregnancy (1997) 1997
humans (1870) 1870
female (1843) 1843
1st trimester (1248) 1248
obstetrics & gynecology (1194) 1194
adult (883) 883
pregnancy trimester, first (523) 523
1st-trimester (517) 517
pregnant women (485) 485
risk (358) 358
gestational age (338) 338
reproductive biology (301) 301
women (293) 293
ultrasound (292) 292
abridged index medicus (289) 289
risk factors (275) 275
obstetrics and gynecology (261) 261
analysis (260) 260
young adult (260) 260
prospective studies (246) 246
preeclampsia (244) 244
ultrasonography, prenatal (241) 241
prenatal diagnosis - methods (222) 222
diagnosis (216) 216
infant, newborn (212) 212
adolescent (209) 209
prenatal diagnosis (209) 209
nuchal translucency (206) 206
down syndrome - diagnosis (198) 198
genetics & heredity (198) 198
pregnancy outcome (197) 197
retrospective studies (192) 192
fetuses (187) 187
radiology, nuclear medicine & medical imaging (187) 187
abortion (186) 186
aneuploidy (184) 184
biomarkers - blood (176) 176
human chorionic-gonadotropin (174) 174
maternal age (172) 172
acoustics (169) 169
down syndrome (167) 167
male (164) 164
down-syndrome (158) 158
middle aged (158) 158
miscarriage (156) 156
placenta (150) 150
gestation (147) 147
health aspects (144) 144
case-control studies (138) 138
first trimester (138) 138
trisomy-21 (132) 132
papp-a (130) 130
risk assessment (130) 130
sensitivity and specificity (130) 130
cohort studies (128) 128
endocrinology & metabolism (128) 128
research (128) 128
ultrasonography, prenatal - methods (127) 127
predictive value of tests (122) 122
crown-rump length (120) 120
early-pregnancy (118) 118
internal medicine (117) 117
pregnancy complications - drug therapy (116) 116
medicine, general & internal (115) 115
developmental biology (114) 114
womens health (114) 114
population (113) 113
nuchal translucency measurement (112) 112
pediatrics (110) 110
animals (108) 108
pharmacology & pharmacy (107) 107
fetus (106) 106
obstetrics (105) 105
pregnancy trimester, second (105) 105
misoprostol (103) 103
pre-eclampsia (103) 103
ultrasonography (101) 101
prenatal-diagnosis (98) 98
prevalence (98) 98
chorionic gonadotropin, beta subunit, human - blood (94) 94
free beta-hcg (93) 93
amniocentesis (92) 92
health risk assessment (92) 92
screening (91) 91
gynecology (88) 88
pregnancy trimester, first - blood (88) 88
immunology (87) 87
management (86) 86
uterine artery doppler (86) 86
pregnancy complications (84) 84
age (83) 83
infants (83) 83
hypertension (82) 82
pregnancy-associated plasma protein-a - analysis (81) 81
serum (81) 81
treatment outcome (81) 81
studies (80) 80
downs-syndrome (79) 79
outcomes (79) 79
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2219) 2219
French (28) 28
German (18) 18
Spanish (3) 3
Polish (2) 2
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 25, pp. 2397 - 2407
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 23, pp. 2245 - 2254
Journal Article
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 6, pp. 1496 - 1502.e7
Journal Article
CMAJ, ISSN 0820-3946, 07/2010, Volume 182, Issue 10, pp. 1031 - 1037
Background: The risk of relapse of depression or the diagnosis of some other psychiatric disorders during pregnancy necessitates the use of antidepressants... 
WOMEN | DEPRESSION | MEDICINE, GENERAL & INTERNAL | GESTATIONAL EXPOSURE | MULTICENTER | PREDICTORS | MISCARRIAGE | 1ST-TRIMESTER EXPOSURE | PREVALENCE | FLUOXETINE | BIRTH OUTCOMES | Confidence Intervals | Cyclohexanols - adverse effects | Humans | Middle Aged | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Case-Control Studies | Paroxetine - adverse effects | Dose-Response Relationship, Drug | Paroxetine - administration & dosage | Young Adult | Drug Therapy, Combination - adverse effects | Abortion, Spontaneous - chemically induced | Adult | Female | Registries | Odds Ratio | Risk Factors | Quebec | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Gestational Age | Pregnancy Complications - drug therapy | Antidepressive Agents - therapeutic use | Pregnancy | Pregnancy Complications - psychology | Venlafaxine Hydrochloride | Antidepressive Agents, Tricyclic - therapeutic use | Depressive Disorder - complications | Adolescent | Antidepressive Agents, Tricyclic - adverse effects | Cyclohexanols - therapeutic use | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Cyclohexanols - administration & dosage | Psychological aspects | Usage | Care and treatment | Antidepressants | Pregnant women | Depression, Mental | Research | Abortion | Health aspects | Risk factors | Studies | Risk | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
International Journal of Gynecology & Obstetrics, ISSN 0020-7292, 2016, Volume 134, Issue 3, pp. 268 - 271
Abstract Objective To evaluate the efficacy of at-home medical abortion in Kazakhstan. Methods A comparative, non-randomized study was undertaken at three... 
Obstetrics and Gynecology | Mifepristone | Kazakhstan | Misoprostol | Home use | Medical abortion | FEASIBILITY | ACCEPTABILITY | 1ST TRIMESTER | OPEN-LABEL | COMBINATION | OBSTETRICS & GYNECOLOGY
Journal Article